These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A study on a possibility of predicting early relapse in leprosy using a ND-O-BSA based ELISA. Wu Q, Yin Y, Zhang L, Chen X, Yu Y, Li Z, Yu H, Lu C, Feng S, Li X, Huo W, Ye G. Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):1-8. PubMed ID: 12120035 [Abstract] [Full Text] [Related]
3. Serological activity of natural disaccharide octyl bovine serum albumin (ND-O-BSA) in sera from patients with leprosy, tuberculosis, and normal controls. Wu QX, Ye GY, Li XY. Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):50-5. PubMed ID: 3131466 [Abstract] [Full Text] [Related]
5. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia. Desforges S, Bobin P, Brethes B, Huerre M, Moreau JP, Bach MA. Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462 [Abstract] [Full Text] [Related]
6. Seroepidemiological study on 724 household contacts of leprosy patients in French Polynesia using disaccharide-octyl-BSA as antigen. Chanteau S, Cartel JL, Guidi C, Plichart R, Bach MA. Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):626-32. PubMed ID: 3323366 [Abstract] [Full Text] [Related]
7. Evaluation of four semi-synthetic Mycobacterium leprae antigens with sera from healthy populations in endemic and non-endemic areas. Douglas JT, Steven LM, Hirsch DS, Fujiwara T, Nelson KE, Madarang MG, Cellona RV. Lepr Rev; 1992 Sep; 63(3):199-210. PubMed ID: 1406016 [Abstract] [Full Text] [Related]
8. Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosy. Brett SJ, Payne SN, Gigg J, Burgess P, Gigg R. Clin Exp Immunol; 1986 Jun; 64(3):476-83. PubMed ID: 2431812 [Abstract] [Full Text] [Related]
9. Rapid serodiagnosis for leprosy--a preliminary study on latex agglutination test. Wu QX, Ye GY, Yin YP, Li XY, Liu Q, Wei WH. Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):328-33. PubMed ID: 2198316 [Abstract] [Full Text] [Related]
10. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy. Agis F, Schlich P, Cartel JL, Guidi C, Bach MA. Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):527-35. PubMed ID: 3065419 [Abstract] [Full Text] [Related]
11. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts. Chujor CS, Bernheimer H, Levis WR, Schwerer B. Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368 [Abstract] [Full Text] [Related]
12. An appraisal of enzyme linked immunosorbent assay (ELISA) and serum antibody competition test (SACT) in leprosy. Kanchana MV, Lakshminarayana CS, Sengupta U, Sinha S, Ramu G. Indian J Lepr; 1992 Sep; 64(1):42-50. PubMed ID: 1573300 [Abstract] [Full Text] [Related]
13. Cross-sectional assessment of ELISA reactivity in leprosy patients, contacts, and normal population using the semisynthetic antigen natural disaccharide octyl bovine serum albumin (ND-O-BSA) in Cebu, The Philippines. Cellona RV, Walsh GP, Fajardo TT, Abalos RM, dela Cruz EC, Guido-Villahermosa L, Felicio-Balagon MV, Steenbergen GJ, Douglas JT. Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):192-8. PubMed ID: 8371027 [Abstract] [Full Text] [Related]
14. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy. Menzel S, Harboe M, Bergsvik H, Brennan PJ. Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365 [Abstract] [Full Text] [Related]
15. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population. Ilangumaran S, Shankernarayan N, Ramu G, Muthukkaruppan V. Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226 [Abstract] [Full Text] [Related]
16. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy. Reece ST, Ireton G, Mohamath R, Guderian J, Goto W, Gelber R, Groathouse N, Spencer J, Brennan P, Reed SG. Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774 [Abstract] [Full Text] [Related]
17. Use of an artificial antigen containing the 3,6-di-O-methyl-beta-D-glucopyranosyl epitope for the serodiagnosis of leprosy. Cho SN, Fujiwara T, Hunter SW, Rea TH, Gelber RH, Brennan PJ. J Infect Dis; 1984 Sep; 150(3):311-22. PubMed ID: 6207246 [Abstract] [Full Text] [Related]
18. HLA and leprosy in the pre and postgenomic eras. Geluk A, Ottenhoff TH. Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267 [Abstract] [Full Text] [Related]
19. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG. Vikerfors T, Olcén P, Wiker H, Watson JD. Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188 [Abstract] [Full Text] [Related]
20. Use of non-conventional antigen: M. habana in detecting M. leprae antibodies from leprosy patients and contacts in FLA-ABS test. Rana NS, Gupta HP, Singh NB. Indian J Lepr; 1988 Oct; 60(4):593-9. PubMed ID: 3075637 [Abstract] [Full Text] [Related] Page: [Next] [New Search]